Following the administration of long-acting SGLT2 inhibitors, the Matsuda–DeFronzo index and the disposition index, which are known as parameters of insulin secretion and insulin resistance, respectively, were also improved, indicating that the SGLT2 inhibitors improve insulin resistance and secretion (61). This evidence concerns the gene INS and Insulin resistance.